Skip to main content

Intraocular Ki-1 lymphoma in a 2-year-old boy.

Publication ,  Journal Article
Young, TL; Himelstein, BP; Rebsamen, SL; Ruchelli, E; Quinn, GE; Bunin, N
Published in: J Pediatr Ophthalmol Strabismus
1996

Duke Scholars

Published In

J Pediatr Ophthalmol Strabismus

DOI

ISSN

0191-3913

Publication Date

1996

Volume

33

Issue

5

Start / End Page

268 / 270

Location

United States

Related Subject Headings

  • Radiotherapy, Adjuvant
  • Ophthalmology & Optometry
  • Male
  • Magnetic Resonance Imaging
  • Lymphoma, Large-Cell, Anaplastic
  • Lymph Nodes
  • Infant
  • Humans
  • Eye Neoplasms
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Young, T. L., Himelstein, B. P., Rebsamen, S. L., Ruchelli, E., Quinn, G. E., & Bunin, N. (1996). Intraocular Ki-1 lymphoma in a 2-year-old boy. J Pediatr Ophthalmol Strabismus, 33(5), 268–270. https://doi.org/10.3928/0191-3913-19960901-14
Young, T. L., B. P. Himelstein, S. L. Rebsamen, E. Ruchelli, G. E. Quinn, and N. Bunin. “Intraocular Ki-1 lymphoma in a 2-year-old boy.J Pediatr Ophthalmol Strabismus 33, no. 5 (1996): 268–70. https://doi.org/10.3928/0191-3913-19960901-14.
Young TL, Himelstein BP, Rebsamen SL, Ruchelli E, Quinn GE, Bunin N. Intraocular Ki-1 lymphoma in a 2-year-old boy. J Pediatr Ophthalmol Strabismus. 1996;33(5):268–70.
Young, T. L., et al. “Intraocular Ki-1 lymphoma in a 2-year-old boy.J Pediatr Ophthalmol Strabismus, vol. 33, no. 5, 1996, pp. 268–70. Pubmed, doi:10.3928/0191-3913-19960901-14.
Young TL, Himelstein BP, Rebsamen SL, Ruchelli E, Quinn GE, Bunin N. Intraocular Ki-1 lymphoma in a 2-year-old boy. J Pediatr Ophthalmol Strabismus. 1996;33(5):268–270.

Published In

J Pediatr Ophthalmol Strabismus

DOI

ISSN

0191-3913

Publication Date

1996

Volume

33

Issue

5

Start / End Page

268 / 270

Location

United States

Related Subject Headings

  • Radiotherapy, Adjuvant
  • Ophthalmology & Optometry
  • Male
  • Magnetic Resonance Imaging
  • Lymphoma, Large-Cell, Anaplastic
  • Lymph Nodes
  • Infant
  • Humans
  • Eye Neoplasms
  • Combined Modality Therapy